Contrast staining of brain parenchyma identified on non-contrast CT performed after DSA in patients with acute ischemic stroke (AIS) is an incompletely understood imaging finding. We hypothesize contrast staining to be an indicator of brain injury and suspect the fate of involved parenchyma to be cerebral infarction.
Seventeen years of AIS data were retrospectively analyzed for contrast staining. Charts were reviewed and outcomes of the stained parenchyma were identified on subsequent CT and MRI.
Thirty-six of 67 patients meeting inclusion criteria (53.7%) had contrast staining on CT obtained within 72 hours after DSA. Brain parenchyma with contrast staining in patients with AIS most often evolved into cerebral infarction (81%). Hemorrhagic transformation was less likely in cases with staining compared with hemorrhagic transformation in the cohort that did not have contrast staining of the parenchyma on post DSA CT (6% versus 25%, respectively, OR 0.17, 95% CI 0.017–0.98, p = 0.02).
Brain parenchyma with contrast staining on CT after DSA in AIS patients was likely to infarct and unlikely to hemorrhage.
ItoUTomitaHKitoK. CT enhancement after prolonged high-dose contrast infusion in the early stage of cerebral infarction. Stroke. 1986; 17: 424–430. doi: 10.1161/01.STR.17.3.424.
2.
NumaguchiYFlemingMSHasuoK. Blood-brain barrier disruption due to cerebral arteriography: CT findings. J Comput Assist Tomogr. 1984; 8 (5): 936–939.
3.
NakanoSIsedaTYoneyamaT. Early CT signs in patients with acute middle cerebral artery occlusion: incidence of contrast staining and haemorrhagic transformations after intra-arterial reperfusion therapy. Clin Radiol. 2006; 61 (2): 156–162. doi: 10.1016/j.crad.2005.08.016.
4.
RobertsHCDillonWPFurlanAJ. Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial. Stroke. 2002; 33 (6): 1557–1565. doi: 10.1161/01. STR.0000018011.66817.41.
5.
KassnerAMandellDMMikulisDJ. Measuring permeability in acute ischemic stroke. Neuroimaging Clin N Am.2011; 21 (2): 315–325. doi: 10.1161/01.STR.0000018011.66817.41.
6.
LeeMSaverJLAlgerJR. Blood-brain barrier permeability derangements in posterior circulation ischemic stroke: frequency and relation to hemorrhagic transformation. J Neurol Sci.2012; 313 (1–2): 142–146. doi: 10.1016/j.jns.2011.08.048.
7.
NakanoSIsedaTKawanoH. Parenchymal hyperdensity on computed tomography after intra-arterial reperfusion therapy for acute middle cerebral artery occlusion: incidence and clinical significance. Stroke. 2001; 32 (9): 2042–2048. doi: 10.1161/hs0901.095602.
8.
YokogamiKNakanoSOhtaH. Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion: value of pre- and post-therapeutic computed tomographic findings and angiographic occlusive site. Neurosurgery. 1996; 39 (6): 1102–1107. doi: 10.1097/00006123-199612000-00006.
BeckerKJBaxterABBybeeHM. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke. 1999; 30: 2025–2032. doi: 10.1161/01.STR.30.10.2025.
11.
WildenhainSLJungreisCABarrJ. CT after intracranial intraarterial thrombolysis for acute stroke. Am J Neuroradiol. 1994; 15 (3): 487–492.
12.
MericleRALopesDKFronckowiakMD. A grading scale to predict outcomes after intra-arterial thrombolysis for stroke complicated by contrast extravasation. Neurosurgery. 2000; 46 (6): 1307–1314; discussion 14–15. doi: 10.1097/00006123-200006000-00005.
13.
ParrillaGGarcia-VillalbaBEspinosa de RuedaM. Hemorrhage/contrast staining areas after mechanical intra-arterial thrombectomy in acute ischemic stroke: imaging findings and clinical significance. Am J Neuroradiol. 2012; 33 (9): 1791–1796. doi: 10.3174/ajnr.A3044.
14.
WolpertSMBruckmannHGreenleeR. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. Am J Neuroradiol. 1993; 14 (1): 3–13.
15.
YoonWSeoJJKimJK. Contrast enhancement and contrast extravasation on computed tomography after intra-arterial thrombolysis in patients with acute ischemic stroke. Stroke. 2004; 35 (4): 876–881. doi: 10.1161/01.STR.0000120726.69501.74.
16.
JangYMLeeDHKimHS. The fate of high-density lesions on the non-contrast CT obtained immediately after intra-arterial thrombolysis in ischemic stroke patients. Korean J Radiol. 2006; 7 (4): 221–228. doi: 10.3348/kjr.2006.7.4.221.
17.
Delgado AlmandozJEYooAJStoneMJ. The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke. 2010; 41: 54–60. doi: 10.1161/STROKEAHA.109.565382.
18.
HackeWKasteMFieschiC. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995; 274 (13): 1017–1025. doi: 10.1001/jama.274.13.1017.
19.
HackeWKasteMFieschiC. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998; 352. doi: 10.1016/S0140-6736(98)08020-9.
20.
BergerCFiorelliMSteinerT. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?Stroke. 2001; 32 (6): 1330–1335. doi: 10.1161/01.STR.32.6.1330.
21.
CovarrubiasDJLuetmerPHCampeauNG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. Am J Neuroradiol. 2002; 23: 1038–1048.
22.
McKinneyAMSarikayaBGustafsonC. Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging. Am J Neuroradiol. 2012; 33 (5): 896–903. doi: 10.3174/ajnr.A2886.
23.
HaubrichCWendtADiehlRR. Dynamic autoregulation testing in the posterior cerebral artery. Stroke. 2004; 35: 848–852. doi: 10.1161/01.STR.0000120729.99039.B6.
24.
KidwellCSChalelaJASaverJL. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 2004; 292 (15): 1823–1830. doi: 10.1001/jama.292.15.1823.
25.
Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke. 1997; 28: 2109–2118. doi: 10.1161/01.STR.28.11.2109.
26.
AmesA3rdWrightRLKowadaM. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol. 1968; 52: 437–453.
27.
del ZoppoGJHallenbeckJM. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res.2000; 98: 73–81. doi: 10.1016/S0049-3848(00)00218-8.
28.
ItoH. No-reflow phenomenon in patients with acute myocardial infarction: its pathophysiology and clinical implications. Acta Med Okayama. 2009; 63: 161–168.
29.
KowadaMAmesA3rdMajnoG. Cerebral ischemia. I. An improved experimental method for study; cardiovascular effects and demonstration of an early vascular lesion in the rabbit. J Neurosurg. 1968; 28 (2): 150–157. doi: 10.3171/jns.1968.28.2.0150.
30.
MolinaCAAlvarez-SabinJ. Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis.2009; 27 (Suppl 1): 162–167. doi: 10.1159/000200455.
